Literature DB >> 18087282

Possible protective effect of green tea intake on risk of adult leukaemia.

M Zhang1, X Zhao, X Zhang, C D'Arcy J Holman.   

Abstract

In a case-control study of 107 adults with leukaemia and 110 orthopaedic controls in China, a reduced risk was found with longer duration, higher quantity, and frequency of green tea intake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18087282      PMCID: PMC2359700          DOI: 10.1038/sj.bjc.6604140

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


Tea is one of the most frequently consumed beverages in the world (Graham, 1992). Different processing of tea leaves yields green, black, or Oolong tea. If tea leaves are immediately heated, then the enzymes that oxidise catechins are inactivated and the result is green tea; if crushed and allowed to undergo enzyme-mediated oxidation, the process results in black tea with its characteristic colour and taste. Oolong tea results from partially oxidised tea leaves (Graham, 1992). There is some evidence of a protective effect of green tea consumption on certain cancers (Zhang ; 2004; 2007; Cabrera ), but no epidemiological data are available on the effect of green tea on adult leukaemia. We therefore conducted a case–control study of the question in southeast China.

MATERIALS AND METHODS

A hospital-based case–control study was conducted in Hangzhou, southeast China. Eligible cases were defined as Chinese, over 15 years old and resident in Zhejiang Province with leukaemia, histopathologically confirmed according to the haematological standards (Zhang, 1998). They were identified by daily searching of medical records in haematology wards at two teaching hospitals of Zhejiang University in 2005–2006; all medical records and laboratory reports were also reviewed to ensure complete ascertainment of cases. A total of 107 patients aged 16–81 years were recruited, most (83.2%) were recent and were interviewed within 12 months of diagnosis. During the same period of data collection, 110 orthopaedic patients without leukaemia or other malignancy were randomly selected as controls to match the cases by age using a daily update of the list of cases. The project received approval from the hospital authorities and from the Human Research Ethics Committee of The University of Western Australia. Subjects were briefed regarding the aims of the study and confidentiality issues. After obtaining their consent, a face-to-face interview was conducted in the hospitals using a structured, validated questionnaire on (a) demography and lifestyle; (b) tea consumption; (c) hazard exposure and family history of malignancy. Most cases were recent patients interviewed within 3–6 months of diagnosis. Details of leukaemia subtype and stage were retrieved from hospital records. Tea consumption was measured using a questionnaire adapted from our previous studies, its reproducibility evaluated in a test–retest study where the intraclass correlation coefficient was 0.83 for tea (Zhang ). Information was sought on preparation method, type of tea drank, duration of each type, frequency of cups (350–400 ml), frequency of new batches of tea brewed, quantity of dried tealeaf consumed per year (in liang, equivalent to 50 g), and date of cessation. Frequency of cups was categorised as never or seldom, once a month, 2–3 times a month, once a week, 2–3, 4–6 times a week, once a day, 2–3, and ⩾4 times a day.

Statistical analysis

The data were coded and analysed using the SPSS package. As none of the participants reported drinking black or Oolong tea only and few (3.8%) drank both green and black tea, all tea drinkers were classified as green tea drinkers. All comparisons used a t-test for continuous variables and χ2-test for categorical variables. Odds ratios (ORs) of adult leukaemia and associated 95% confidence intervals (CIs) for green tea consumption as an explanatory variable were estimated using unconditional logistic regression. Multivariate models included potential confounders identified using univariate analysis and risk factors reported in other studies (Miligi ; Ross ; Kasim ).

RESULTS

Of leukaemia subtypes, 72 (67.3%) were acute myeloid leukaemia (AML), 22 (20.6%) acute lymphocytic leukaemia (ALL), 10 (9.3%) chronic myeloid leukaemia (CML), and 3 (2.8%) chronic lymphocytic leukaemia (CLL). Selected characteristics are shown in Table 1. Cases were more educated, more exposed to chloromycetin, benzene, and organophosphorus, but fewer were smokers, especially among the men. Notably, only 42.1% of cases were tea drinkers compared with 55.4% of controls. Among the 106 tea drinkers, 96.2% drank green tea only. No other differences were found in the characteristics covered in Table 1.
Table 1

Selected characteristics of cases and controls

  Cases (n=107) Controls (n=110) P-valuea
Age at interview (years) 42.9±16.444.5±16.90.46
 15–<3025 (23.3)24 (21.8) 
 30–<4534 (31.8)34 (30.9) 
 45–<6028 (26.2)27 (24.5) 
 ⩾6020 (18.7)25 (22.7) 
    
Gender   0.77
 Male66 (61.7)70 (63.6) 
 Female41 (38.3)40 (36.4) 
    
Locality of resident   0.37
 Metropolitan29 (27.1)24 (21.8) 
 Suburb or rural area78 (72.9)86 (78.2) 
    
Education   0.02
 No formal education12 (11.2)6 (5.4) 
 Primary24 (22.4)29 (26.4) 
 Secondary49 (45.8)66 (60.0) 
 Tertiary22 (20.6)9 (8.2) 
    
Tobacco smoking    
 Male smokers29 (43.9)45 (64.3)0.02
 Female smokers0 (0)3 (7.5)0.07
    
Overall tea consumption 45 (42.1)61 (55.4)<0.05
 Green tea only45 (42.1)57 (51.8) 
 Black tea only0 (0)0 (0) 
 Oolong tea only0 (0)0 (0) 
 Green and black tea0 (0)4 (3.6) 
Medication use of chloromycetin6 (5.6)0 (0)0.01
Occupational benzene exposure16 (15.0)1 (0.9)<0.001
Occupational organophosphorus exposure5 (4.7)0 (0)0.02

Values expressed as mean±s.d. or number (%).

Two-sided t-test for continuous variables and χ2-test for categorical variables.

Selected characteristics of green tea drinkers and nontea drinkers are presented in Table 2. Compared with nontea drinkers, green tea drinkers tended to be older and more often male (72 vs 54%). There was no significant difference in residential area, education, or smoking.
Table 2

Selected characteristics of green tea drinkers and nontea drinkers

  Green tea drinkers (n=106) Nontea drinkers (n=111) P-valuea
Age at interview (years)48.1±14.939.5±17.2<0.001
    
Gender   <0.01
 Male76 (71.7)60 (54.1) 
 Female30 (28.3)51 (45.9) 
    
Locality of resident   0.19
 Metropolitan30 (28.3)23 (20.7) 
 Suburb or rural area76 (71.7)88 (79.3) 
    
Education   0.51
 No formal education9 (8.5)9 (8.1) 
 Primary28 (26.4)25 (22.5) 
 Secondary51 (48.1)64 (57.7) 
 Tertiary18 (17.0)13 (11.7) 
    
Tobacco smoking   0.40
 Male smokers43 (56.6)31 (51.7) 
 Female smokers1 (3.3)2 (3.9) 

Values expressed as mean±s.d. or number (%).

Two-sided t-test for continuous variables and χ2-test for categorical variables.

Compared with nontea drinkers or infrequent tea drinkers, the adjusted ORs and associated 95% CIs were 0.39 (0.17–0.91), 0.20 (0.06–0.60), 0.40 (0.19–0.82), and 0.42 (0.20–0.86) in those who consumed green tea at ⩾1001 g of dried tea leaves per annum, for >20 years, at ⩾1 cup a day, and at ⩾1 new batches a day, respectively (Table 3). A significant dose–response relationship between green tea consumption and adult leukaemia risk was observed across all measures; the reduced risk was seen for ALL and CML/CLL combined, but not for AML.
Table 3

Associations between green tea consumption and the risk of adult leukaemia

  No. of cases No. of controls Adjusted OR (95% CI)a
Tea drinking
 No62491.0 (referent)
 Yes45610.51 (0.27–0.96)
Ptrendb  0.04
    
Duration (years)
 062491.0 (referent)
 ⩽1020210.68 (0.30–1.53)
 >10 to ⩽2011170.66 (0.26–1.72)
 >2014230.20 (0.06–0.60)
Ptrendb  <0.01
    
Number of cups
 Nondrinkers or ⩽1 time a week67501.0 (referent)
 2–6 times a week10130.40 (0.14–1.14)
 ⩾1 time a day30470.40 (0.19–0.82)
Ptrendb  <0.01
    
Number of new batches
 Nondrinkers or ⩽1 time a week67501.0 (referent)
 2–6 times a week11140.35 (0.12–1.01)
 ⩾1 time a day29460.42 (0.20–0.86)
Ptrendb  0.01
    
Dried tea leaves (g year1)
 062491.0 (referent)
 ⩽5001471.98 (0.67–5.81)
 501–100012160.20 (0.07–0.62)
 ⩾100119380.39 (0.17–0.91)
Ptrendb  <0.01

CI=confidence interval; OR=odds ratio.

Estimates from separate unconditional logistic regression models included terms for age (years; continuous), gender (male, female), residence (metropolitan, suburb or rural), education (none, primary, secondary, tertiary), smoking (never/ever), medication use of chloromycetin (no/yes), occupational exposure to benzene (no/yes), and organophosphorus (no/yes).

Two-sided test for trend across quantitative or ordinal quantitative variables.

DISCUSSION

This case–control study found that higher intake of green tea was associated with a reduced risk of adult leukaemia and with significant dose–response relationships, the first such evidence, although a US hospital-based case–control study recently reported a negative association between black tea and AML in women (Li ). Our findings are consistent with experimental evidence that green tea polyphenols inhibited proteasome and induced apoptosis in leukaemic cells (Smith ). The few identified risk factors in adult leukaemia account for only a small proportion of cases and include ionising radiation, exposure to benzene, pesticides, immunosuppression, chemotherapy, and smoking (Miligi ; Ross ; Kasim ). We found no significant association of smoking with leukaemia risk, the proportion of smokers being higher in the controls. No association was found between AML and green tea intake. The case–control design may have introduced bias and the study size was relatively small, although recruitment was carefully conducted. The response rate was high, and the matched controls were randomly selected from the same hospitals. Most patients in China are self-referred, and the recruitment procedure ensured that cases and controls came from the same populations. Selection bias among controls from convenience or clinician contact was also minimised. Details were obtained on tea consumption as well as on lifestyle factors and exposures using a validated instrument, designed for residents in southeast China. Our research interest in any type of tea consumption was revealed at the time of the interview to explain why the questions on tea were so detailed. We consider the likelihood of any information bias to have been low, and it is relevant that there had been no mention in the popular media of any link between tea and leukaemia. We found a higher proportion of nontea drinkers than in previous studies and that tea drinking was associated with older age. Although tea consumption can be reported with reasonable accuracy, misclassification may still occur. However, when nondifferential, such errors are likely to bias results towards the null and could not account for the significant inverse associations. Exposure of cases to risk factors may change due to disease status, but most were newly diagnosed within 3–6 months. In conclusion, this study suggests that a higher intake of green tea is associated with a reduced risk of adult leukemia, but the finding needs to be checked in larger studies.
  11 in total

1.  Environmental tobacco smoke and risk of adult leukemia.

Authors:  Khaled Kasim; Patrick Levallois; Belkacem Abdous; Pierre Auger; Kenneth C Johnson
Journal:  Epidemiology       Date:  2005-09       Impact factor: 4.822

2.  A quantitative food frequency questionnaire for women in southeast China: development and reproducibility.

Authors:  M Zhang; C W Binns; A H Lee
Journal:  Asia Pac J Public Health       Date:  2005       Impact factor: 1.399

3.  Green tea and the prevention of breast cancer: a case-control study in Southeast China.

Authors:  Min Zhang; C D'Arcy J Holman; Jiang-ping Huang; Xing Xie
Journal:  Carcinogenesis       Date:  2006-12-20       Impact factor: 4.944

4.  Green tea composition, consumption, and polyphenol chemistry.

Authors:  H N Graham
Journal:  Prev Med       Date:  1992-05       Impact factor: 4.018

5.  Intakes of selected food groups and beverages and adult acute myeloid leukemia.

Authors:  Yulin Li; Kirsten B Moysich; Maria R Baer; Joli R Weiss; John Brasure; Saxon Graham; Susan E McCann
Journal:  Leuk Res       Date:  2006-05-05       Impact factor: 3.156

6.  Diet and risk of leukemia in the Iowa Women's Health Study.

Authors:  Julie A Ross; Christine M Kasum; Stella M Davies; David R Jacobs; Aaron R Folsom; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-08       Impact factor: 4.254

7.  Tea consumption and ovarian cancer risk: a case-control study in China.

Authors:  Min Zhang; Colin W Binns; Andy H Lee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-08       Impact factor: 4.254

Review 8.  Beneficial effects of green tea--a review.

Authors:  Carmen Cabrera; Reyes Artacho; Rafael Giménez
Journal:  J Am Coll Nutr       Date:  2006-04       Impact factor: 3.169

9.  Green tea consumption enhances survival of epithelial ovarian cancer.

Authors:  Min Zhang; Andy H Lee; Colin W Binns; Xing Xie
Journal:  Int J Cancer       Date:  2004-11-10       Impact factor: 7.396

10.  Synthetic analogs of green tea polyphenols as proteasome inhibitors.

Authors:  David M Smith; Zhigang Wang; Aslamuzzaman Kazi; Lian-Hai Li; Tak-Hang Chan; Q Ping Dou
Journal:  Mol Med       Date:  2002-07       Impact factor: 6.354

View more
  13 in total

Review 1.  Tea and health: preventive and therapeutic usefulness in the elderly?

Authors:  Bradley W Bolling; Chung-Yen Oliver Chen; Jeffrey B Blumberg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

2.  Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP cohort.

Authors:  Xiaomei Ma; Yikyung Park; Susan T Mayne; Rong Wang; Rashmi Sinha; Albert R Hollenbeck; Arthur Schatzkin; Amanda J Cross
Journal:  Am J Epidemiol       Date:  2009-12-30       Impact factor: 4.897

Review 3.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

4.  Tea consumption and leukemia risk: a meta-analysis.

Authors:  Shanliang Zhong; Zhiyuan Chen; Xinnian Yu; Weixian Chen; Mengmeng Lv; Tengfei Ma; Jianhua Zhao
Journal:  Tumour Biol       Date:  2014-02-07

Review 5.  Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Authors:  Moshe Frenkel; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2017-10-14       Impact factor: 5.075

6.  Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; Timothy G Call; Clive S Zent; Jose F Leis; Betsy LaPlant; Deborah A Bowen; Michelle Roos; Kristina Laumann; Asish K Ghosh; Connie Lesnick; Mao-Jung Lee; Chung S Yang; Diane F Jelinek; Charles Erlichman; Neil E Kay
Journal:  Cancer       Date:  2012-07-03       Impact factor: 6.860

Review 7.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

8.  Green tea consumption and glutathione S-transferases genetic polymorphisms on the risk of adult leukemia.

Authors:  Ping Liu; Min Zhang; Xing Xie; Jie Jin; C D'Arcy J Holman
Journal:  Eur J Nutr       Date:  2015-11-17       Impact factor: 5.614

9.  Population versus hospital controls for case-control studies on cancers in Chinese hospitals.

Authors:  Lin Li; Min Zhang; D'Arcy Holman
Journal:  BMC Med Res Methodol       Date:  2011-12-15       Impact factor: 4.615

10.  Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies.

Authors:  Jianping Liu; Jianmin Xing; Yutong Fei
Journal:  Chin Med       Date:  2008-10-22       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.